David Agus
Co-Founder @ Project Rōnin
Beverly Hills, United States
David Agus is a Series A investor at Project Rōnin in Beverly Hills focused on Health Care and Health Diagnostics. Dr. David B. Agus is one of the world’s leading doctors and pioneering biomedical researchers. He is the founding director and CEO of the Lawrence J. Ellison Institute for Transformative Medicine and a professor of medicine and engineering at the University of Southern California. A medical oncologist, Dr. Agus leads a multidisciplinary team ofresearchers dedicated to the development and use of technologies to guide doctors in making health-care decisions tailored to individual needs. An international leader in global health and approaches for personalized healthcare, Dr. Agus serves in leadership roles at the World Economic Forum and is co-chair of the Global Health Security Consortium. He is also a CBS News contributor. Dr. Agus’ three books The End of Illness, A Short Guide to a Long Life, and The Lucky Years: How to Thrive in the Brave New World of Health, are all New York Times and international bestsellers, with a new book, The Book of Animal Secrets: Nature’s Lessons for a Long and Happy Life, set for release in March 2023. He is a 2017 recipient of the Ellis Island Medal of Honor.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries David Agus invests in
Stages David Agus invests in
Countries David Agus invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Health Care 1 (100%)
- Health Diagnostics 1 (100%)
- Artificial Intelligence 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Imagene AI
|
Imagene AI provides AI-based molecular testing for cancer, leveraging the patient's histological data for personalized therapy.Our mission at Imagene is to assist cancer patients in receiving the optimal treatment medicine can offer by leveraging AI to detect, in real-time, a broad range of cancerous biomarkers and genomic insights from thebiopsy image alone. By doing so, Imagene overcomes economical, logistical, and technological barriers to reach the full potential of precision medicine for cancer patients.Through collaborations with top-tier medical centers and pharmaceutical companies, Imagene is revolutionizing molecular screening for both clinical practice and research.Our success derives from our cutting-edge technology and talented multidisciplinary team of data scientists, biologists, software engineers, and medical experts. | $18.5M / Series A / May 02, 2022 |
About Project Rōnin
Project Rōnin is a mission to transform cancer care by helping doctors and patients make better-informed decisions about treatment. Our cancer intelligence software provides all the information physicians need, in one place, to assess patient care options and take action. We use predictive technology to present doctors with different scenarios thatcan help them further optimize care. And, we bring the patient voice to the physician by allowing patients to report symptoms, side effects, and disease progression information via our mobile app, enabling real-time symptom management and true shared decision making with the care team.Project Rōnin was founded by Dave Hodgson, one of the world’s leading architects of smart technology for doctors and patients; renowned cancer expert Dr. David Agus; serial health entrepreneur Rowan Chapman, PhD; and tech visionary Larry Ellison.
Project Rōnin Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Dave Hodgson
CEO
|
|||
|
David Agus
Co-Founder
|
|||
Melanie Williams
Director Of Product Design
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does David Agus invest in?
David Agus invests primarily in Health Care, Health Diagnostics and Artificial Intelligence startups, most often at Series A stage. Most of the 1 investments tracked by Shizune back companies in Israel. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact David Agus?
Public channels for David Agus include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did David Agus last invest?
The most recent investment recorded for David Agus closed in May 2022. Shizune tracks 1 investment in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
